Hinge Health, Inc. HNGE
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 800.82M | 720.06M | 646.34M | 587.86M | 534.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 800.82M | 720.06M | 646.34M | 587.86M | 534.39M |
| Cost of Revenue | 113.77M | 111.32M | 122.94M | 118.56M | 113.17M |
| Gross Profit | 687.05M | 608.75M | 523.41M | 469.30M | 421.22M |
| SG&A Expenses | 401.13M | 384.97M | 673.99M | 646.46M | 615.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.83M | 1.74M | 2.59M | 1.08M | 933.00K |
| Total Operating Expenses | 650.65M | 626.39M | 1.17B | 1.13B | 1.09B |
| Operating Income | 150.17M | 93.67M | -527.44M | -546.37M | -552.72M |
| Income Before Tax | 166.31M | 110.95M | -509.46M | -527.26M | -533.31M |
| Income Tax Expenses | -2.01M | 1.88M | 816.00K | 1.00M | -73.00K |
| Earnings from Continuing Operations | 168.31 | 109.07 | -510.27 | -528.26 | -533.24 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 168.31M | 109.07M | -510.27M | -528.26M | -533.24M |
| EBIT | 150.17M | 93.67M | -527.44M | -546.37M | -552.72M |
| EBITDA | 153.05M | 95.69M | -525.34M | -544.24M | -550.54M |
| EPS Basic | 2.09 | 1.36 | -12.29 | -4.81 | -3.23 |
| Normalized Basic EPS | 1.31 | 0.88 | -7.67 | -7.21 | -6.27 |
| EPS Diluted | 1.97 | 1.29 | -12.33 | -11.44 | -9.84 |
| Normalized Diluted EPS | 1.23 | 0.83 | -7.70 | -7.85 | -6.89 |
| Average Basic Shares Outstanding | 317.98M | 315.97M | 280.93M | 217.64M | 151.82M |
| Average Diluted Shares Outstanding | 336.88M | 329.21M | 289.72M | 300.07M | 229.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |